Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Osama R. Mawlawi Image

      Osama R. Mawlawi, Ph.D., FAAPM, FACR

      Department of Imaging Physics, Division of Diagnostic Imaging

      About Dr. Osama R. Mawlawi

      Dr. Mawlawi is a Tenured Professor of Imaging Physics and the Section Chief of Nuclear Medicine Physics at the University of Texas MD Anderson Cancer Center. He started his Medical Physics career at Memorial Sloan Kettering Cancer Center in New York as a research assistant from 1990-1998. He later joined Columbia University School of Physicians and Surgeons as an Assistant Professor from 1998-2001 before coming to MDACC in 2001. Dr. Mawlawi has extensive expertise in PET imaging of biomarkers in preclinical applications and in Phase I-III clinical trials. His primary interest focuses on investigating factors affecting absolute quantification of PET/CT images. His ongoing research is aimed at developing novel techniques for PET/CT image acquisition, correction and reformation, as well as modeling the distribution of novel radiotracers. He has authored over 100 peer reviewed articles and book chapters and is the recipient of several grants from industry and professional societies. Dr. Mawlawi is also an active member of several professional societies such as the SNMMI, AAPM, IEEE, RSNA and ACR where he serves in various roles such as task group chair, board member, or review committee and is the past president of the American Board of Science in Nuclear Medicine (ABSNM). Dr. Mawlawi also serves on multiple institutional committees such as the IRG, CRC, RSC, and ECFS. He has won numerous awards, most recently the MD Anderson's President's Recognition for Faculty Excellence Award in 2014. Dr. Mawlawi is frequently invited as a presenter at national and international conferences. He is board certified in Nuclear Medicine Physics and instrumentation by the ABSNM and in Diagnostic Radiologic Physics by the ABR.
      Read More

      Present Title & Affiliation

      Primary Appointment

      Section Chief, Nuclear Medicine Physics Section, The University of Texas MD Anderson Cancer Center, Houston, TX

      Professor, Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Faculty, Graduate School of Biomedical Sciences, Houston, TX

      Research Interests

      His research interests are focused on Nuclear Medicine physics with specific focus on PET/CT imaging.

      Areas of specialization include: 

      PET/CT and PET/MR image formation, quantification and accuracy  |  Radionuclide dosimetry  |  Kinetic modeling

      The research in his laboratory is directed at functional imaging using Positron Emission Tomography (PET). A strong interest lies in the factors affecting absolute quantification of PET images such as partial volume, scatter, and patient motion artifacts. Ongoing research is looking at novel techniques of image acquisition, correction and formation. Other interests lie in modeling the distribution of novel radiotracers to image specific biochemical processes such as metabolism, blood flow, receptor binding and expression.

      A tutorial in his lab would provide the student with an in-depth experience of functional imaging using PET. Moreover, the student will get hands-on experience with image acquisition, reconstruction, and analysis software tools.

      Clinical Interests

      PET/CT, SPECT/CT, and Nuclear Medicine imaging  |  Quality control, assurance, and improvement of Nuclear Medicine and PET imaging

      Education & Training

      Degree-Granting Education

      1998Columbia University, New York, New York, US, Biomedical Engineering, Ph.D
      1990Polytechnic University, Brooklyn, New York, US, Biomedical Engineering, M.S
      1988American University of Beirut, Beirut, LB, Electrical Engineering, BE

      Licenses & Certifications

      2013Arizona Radiation Regulatory, Diagnostic X-Ray and Nuclear Medicine License
      2009Texas Board of Licensure for Professional Medical Physicists; Diagnostic Radiological Physics
      2009American Board of Radiology Diagnostic Radiological Physics
      2003American Board of Science in Nuclear Medicine (ABSNM)
      2003Texas Board of Licensure for Professional Medical Physicists; Medical Nuclear Physics

      Experience & Service

      Administrative Appointments/Responsibilities

      Deputy Department Chair, Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present

      Past Chair, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019

      Chair, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2018

      Chair-Elect, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2017

      Director, Physician Scientist Advanced Scholar Program, Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - Present

      Section Chief, Nuclear Medicine Physics Section, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present

      Mentoring Program Coordinator, Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2018

      Nuclear Medicine Research Peer Review Committee, Imaging Physics - Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - Present

      Imaging Physics Research Committee Member, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - Present

      Imaging Physics Residency Program Steering Committee, Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - Present

      Medical Physics Graduate Program Steering Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2013

      Other Professional Positions

      Affiliate, Institute for Data Science in Oncology (IDSO), MD Anderson Cancer Center, 2025 - Present

      President Elect, American Board of Science in Nuclear Medicine, Reston, VA, 2025 - 2026

      Past President, Society of Nuclear Medicine and Molecular Imaging (SNMMI), Physics Instrumentation and Data Science (PIDS) Council, Reston, VA, 2021 - 2022

      Chair, American College of Radiology, Nuclear Medicine Physics Accreditation Subcommittee, Reston, VA, 2020 - 2024

      President, Society of Nuclear Medicine and Molecular Imaging (SNMMI), Physics Instrumentation and Data Science (PIDS) Council, Reston, VA, 2020 - 2021

      President Elect, Society of Nuclear Medicine and Molecular Imaging (SNMMI), Physics Instrumentation and Data Science (PIDS) Council, Reston, VA, 2019 - 2020

      Past President, Board of Directors, American Board of Science in Nuclear Medicine, Reston, VA, 2013 - 2015

      President, Board of Directors, American Board of Science in Nuclear Medicine, Reston, VA, 2011 - 2013

      Treasurer, Society of Nuclear Medicine, Computer and Instrumentation Council, Reston, VA, 2010 - 2012

      President Elect, Board of Directors, American Board of Science in Nuclear Medicine, Reston, VA, 2010 - 2011

      Member, Board of Directors, American Board of Science in Nuclear Medicine, Reston, VA, 2009 - Present

      Consultant, International Atomic Energy Agency (IAEA), Houston, TX, 2008 - 2020

      Consultant, American College of Radiology (ACR), Reston, Virginia, 2006 - Present

      Contract consultant, Amgen Inc, Thousand Oaks, CA, 2006 - 2009

      Extramural Institutional Committee Activities

      Member, Theranostics Program Development Committee TPDC, The University of Texas MD Anderson Cancer Center, 2026 - Present

      Member, Institutional Conflict of Interest, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Member, Search Committee Member for Chair of the Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 2022

      Search Committee Member for Division Head of Anesthesiology, Critical Care & Pain Medicine, The University of Texas MD Anderson Cancer Center, 2021

      Search Committee Member for Director, Faculty and Academic Wellness, The University of Texas MD Anderson Cancer Center, 2021

      Search Committee Member for Director, Center for Professionalism Standards and Support, The University of Texas MD Anderson Cancer Center, 2021

      Parliamentarian, Faculty Senate Executive Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2022

      Member, Strategic Planning Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present

      Member, Institutional Conflict of Interest Committee, MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2018 - 2019

      Chair, Chair of Search Committee for the Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 2018 - 2019

      Member, Search Committee Member for Chief Academic Officer of MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2018

      Co-Chair, Search Committee Member for Vice Chair of Research in Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 2018

      Member, Search Committee Member for Chair of Radiation Physics, MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2018

      Member, Technology Task Force, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 2017 - Present

      Member, Search Committee for President of MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2017

      Member, Search Committee for Director of PET/MR in Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 2017

      Co-Chair, Search Committee for Section Chief of Abdominal Imaging in Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 2017

      Co-Chair, Faculty Functional Committee, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Member, Faculty Research Committee, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Member, Faculty Education Committee, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Member, Faculty Functional Committee, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, 2014 - 2016

      Member, Faculty Mentoring Advisory Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Member, Executive Committee of the Faculty Senate (ECSF), The University of Texas MD Anderson Cancer Center, 2013 - 2022

      Member, Radiation Safety Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present

      Imaging Physics Representative, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2012 - 2019

      Member, Study Section Review Committee for Clinical Translational and Population-Based Research Projects; Institutional Research Grants Program, The University of Texas MD Anderson Cancer Center, 2011 - 2014

      Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2009 - 2011

      Member, Study section review committee for Basic Research Projects; Institutional Research Grants Program, The University of Texas MD Anderson Cancer Center, 2008 - 2011

      Member, Clinical Research Committee (CRC), The University of Texas MD Anderson Cancer Center, 2006 - 2009

      Member, PET/CT Strategic Planning Committee, The University of Texas MD Anderson Cancer Center, 2003 - 2008

      Member, PACS Steering Committee, The University of Texas MD Anderson Cancer Center, 2003 - 2008

      Editorial Activities

      Associate Editor, European Journal of Nuclear Medicine and Molecular Imaging Physics, 2013 - 2018

      Associate Editor, Journal of Applied Clinical Medical Physics, 2010 - Present

      Associate Editor, Medical Physics Journal, 2004 - Present

      Honors & Awards

      2025Fellow, Society of Nuclear Medicine and Molecular Imaging
      2024Diagnostic Imaging Citizenship Award, The University of Texas MD Anderson Cancer Center
      2019 - PresentRe-Award of Tenure, The University of Texas MD Anderson Cancer Center
      2018Fellow, American College of Radiology
      2017President’s Recognition for Faculty Excellence - Excellence in Financial Stewardship, The University of Texas MD Anderson Cancer Center
      2014President’s Recognition for Faculty Excellence, The University of Texas MD Anderson Cancer Center
      2013Fellow, American Association of Physicist in Medicine
      2011Re-Award of Tenure, The University of Texas MD Anderson Cancer Center
      2005Tenure, The University of Texas MD Anderson Cancer Center
      2005Outstanding Contributions to JNMT, Society of Nuclear Medicine
      1997Scientific Exhibits Section of the Society of Nuclear Medicine, Society of Nuclear Medicine

      Professional Memberships

      American Association of Physicists in Medicine

      2022 - Present

      Society of Nuclear Medicine and Molecular Imaging

      2022 - Present

      American Association of Physicists in Medicine

      2022 - Present

      American Association of Physicists in Medicine

      2022 - Present

      American Association of Physicists in Medicine

      2022 - Present

      American College of Radiology

      2022 - 2024

      American Association of Physicists in Medicine

      2022 - 2024

      Society of Nuclear Medicine and Molecular Imaging

      2021 - Present

      Society of Nuclear Medicine Awards Committee

      2018 - 2022

      American Association of Physicists in Medicine TG174: Utilization of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Radiation Therapy

      2014 - 2019

      American Association of Physicists in Medicine, Awards Selection Subcommittee

      2012 - Present

      American Association of Physicists in Medicine

      2012 - 2017

      American Board of Science in Nuclear Medicine

      2011 - Present

      American Association of Physicists in Medicine TG211: Classification, Advantages and Limitations of the Auto-Segmentation Approaches for PET

      2011 - 2017

      American Association of Physicists in Medicine Middle East Affairs Subcommittee

      2010 - 2023

      Society of Directors of Academic Medical Physics Program

      2010 - 2016

      Society of Nuclear Medicine

      2010 - 2012

      American Association of Physicists in Medicine

      2008 - Present

      American Association of Physicists in Medicine TG126: PET/CT Acceptance Testing and Quality Assurance

      2008 - 2019

      American Association of Physicists in Medicine TG145: Quantitative Imaging initiative: Quantitative PET/CT Imaging

      2006 - Present

      American College of Radiology, Nuclear Medicine Physics Accreditation Subcommittee

      2006 - Present

      American College of Radiology, Nuclear Medicine Accreditation Program

      2006 - Present

      American College of Radiology

      2006 - Present

      American Association of Physicists in Medicine

      2001 - Present

      Society of Nuclear Medicine

      1998 - Present

      IEEE Society of Nuclear and Plasma Science

      1998 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2012. Nuclear Medicine Breast Imaging. Conference. Nuclear Medicine Breast Imaging. Houston, TX, US.
      2. 2011. Sources and remedies of variability in PET SUV measurements. Conference. Sources and remedies of variability in PET SUV measurements. Houston, TX, US.
      3. 2010. Factors affecting quantification in PET and PET/CT imaging. Conference. Factors affecting quantification in PET and PET/CT imaging. Houston, TX, US.
      4. 2004. PET/CT: the hows and whys behind this imaging modality. Conference. PET/CT: the hows and whys behind this imaging modality. Houston, TX, US.

      National Presentations

      1. 2026. ACR Positron Emission Tomography QC Manual. Conference. Vancouver, CA.
      2. 2025. Total Body PET / CT Imaging: Current and Future Status of This Technology Innovation. Conference. American Association of Physicist in Medicine (AAPM). Washington, D.C, District of Columbia, US.
      3. 2025. PET Fundamental Principles. Conference. Nuclear Medicine Review Course. Washington, District Columbia, US.
      4. 2025. NM and PET Accreditation Program Updates. Conference. Washington, DC, US.
      5. 2025. Challenges and potential solutions to clinical trials - a physicist perspective. Invited. Virtual, US.
      6. 2024. Radiation Dose Comparison: PET/CT vs PET/MR. Conference. Radiological Society of North America (RSNA) 110th Scientific Assembly and Annual Meeting. Chicago, IL, US.
      7. 2024. Technical Update: Recent Innovations in Thoracic PET-CT. Conference. Radiological Society of North America (RSNA) 110th Scientific Assembly and Annual Meeting. Chicago, IL, US.
      8. 2024. PET fundamental principles. Conference. Nuclear medicine review course. Los Angeles, CA, US.
      9. 2024. Advances in PET/CT Imaging. Conference. Advanced Course on Biomedical Imaging, PT.
      10. 2024. PET I: Basics. Conference. Advanced Course on Biomedical Imaging, PT.
      11. 2024. QC of Novel Imaging Devices & Equipment. Invited. IAEA Interregional Training Course on Train-the-Trainer on QUANUM and the Patient Journey Audit Tool. Houston, TX, US.
      12. 2023. What is new in Nuclear Medicine from NM physicist perspective. Conference. What is new in Nuclear Medicine from NM physicist perspective. Chicago, IL, US.
      13. 2023. Advances and Quantification in PET/CT. Conference. Advances and Quantification in PET/CT. Houston, TX, US.
      14. 2023. PET fundamental principles. Conference. Nuclear medicine review course. Houston, TX, US.
      15. 2023. Quadra PET/CT. Conference. Quadra PET/CT. Chicago, IL, US.
      16. 2022. Digital PET in Current Radiology Practice: State of the Art PET Technology from GE. Conference. Digital PET in Current Radiology Practice: State of the Art PET Technology from GE. Chicago, IL, US.
      17. 2022. Medical Physics Cross-Specialization in the Era of Radiotheranostics. Conference. Medical Physics Cross-Specialization in the Era of Radiotheranostics. Washington, DC, DC, US.
      18. 2022. PET fundamental principles. Conference. Nuclear medicine review course. Washington, DC, US.
      19. 2022. ACR Updates Including the New Stereotactic Breast Biopsy QC Manual. Conference. ACR Updates Including the New Stereotactic Breast Biopsy QC Manual. Washington, DC, DC, US.
      20. 2022. Quantification in PET/CT Imaging. Conference. Quantification in PET/CT Imaging. San Antonio, TX, US.
      21. 2021. Digital PET in Current Radiology Practice: State of the Art PET technology from GE. Conference. Digital PET in Current Radiology Practice: State of the Art PET technology from GE. Chicago, IL, US.
      22. 2021. Advances and Quantification in PET/CT. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      23. 2021. PET fundamental principles. Conference. American Association of Physicist in Medicine (AAPM); Virtually. Washington, DC, US.
      24. 2021. PET/CT Acceptance Testing and Quality Assurance: AAPM TG126. Conference. PET/CT Acceptance Testing and Quality Assurance: AAPM TG126, US.
      25. 2020. Innovations in Hybrid Imaging: Recent Advances in PET Imaging. Conference. Innovations in Hybrid Imaging: Recent Advances in PET Imaging, US.
      26. 2020. ACR Update in Nuclear Medicine “Physics” Accreditation. Conference. ACR Update in Nuclear Medicine “Physics” Accreditation, US.
      27. 2020. Academic, Clinical and Industrial Pathways for Nuclear Medicine Physicists, Engineers and Data Scientists Webinar. Conference. Academic, Clinical and Industrial Pathways for Nuclear Medicine Physicists, Engineers and Data Scientists Webinar, US.
      28. 2020. Technological Developments and Fundamentals of Quantitative PET. Conference. Technological Developments and Fundamentals of Quantitative PET, FL, US.
      29. 2020. Quality Control Acceptance Testing and Quantitative Imaging. Conference. Quality Control Acceptance Testing and Quantitative Imaging, FL, US.
      30. 2019. Innovations in PET/CT. Conference. Innovations in PET/CT. Chicago, US.
      31. 2019. Technological Advances in PET Imaging. Conference. Technological Advances in PET Imaging. Anaheim, CA, US.
      32. 2019. Recent Advances in PET Imaging. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      33. 2019. Theoretical Aspects of PET/CT. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      34. 2018. PET/CT Introduction and Clinical Applications. Conference. PET/CT Introduction and Clinical Applications. Chicago, IL, US.
      35. 2018. Solid Slate Photo Detection PET Instrumentation and Technology – Discovery MI PET/CT and Signa PET/MR. Conference. Solid Slate Photo Detection PET Instrumentation and Technology – Discovery MI PET/CT and Signa PET/MR. Nashville, TN, US.
      36. 2018. Update on PET Testing TG126 – Physics Testing of Gamma Cameras and PET Scanners: Reports from TG 177 and TG126. Conference. Update on PET Testing TG126 – Physics Testing of Gamma Cameras and PET Scanners: Reports from TG 177 and TG126. Nashville, TN, US.
      37. 2018. Advances in PET Imaging. Conference. Advances in PET Imaging. Winston-Salem, NC, US.
      38. 2018. Quantification Challenges in PET/CT Imaging. Conference. Quantification Challenges in PET/CT Imaging. Winston-Salem, NC, US.
      39. 2018. PET/CT Instrumentation. Conference. PET/CT Instrumentation. Houston, TX, US.
      40. 2018. Advances and Quantification in PET/CT Imaging. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      41. 2018. Basic Principles of PET Imaging. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      42. 2018. Advances in NM/PET Imaging. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      43. 2017. New Generation Solid State LightBurst PET. Conference. New Generation Solid State LightBurst PET. Denver, CO, US.
      44. 2017. Board Certification from the ABR. Conference. Board Certification from the ABR. Denver, CO, US.
      45. 2017. Solid State LightBurst New PET Technology - GE PET/CT and PET/MR. Conference. Solid State LightBurst New PET Technology - GE PET/CT and PET/MR. Denver, CO, US.
      46. 2017. Team Based Nuclear Medicine: Best Practices. Conference. Team Based Nuclear Medicine: Best Practices. Denver, CO, US.
      47. 2016. Advances and Quantification in PET/CT. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      48. 2016. AAPM/RSNA Basic Physics Lecture for the RT: Hybrid Imaging: Past, Present and Future. Conference. AAPM/RSNA Basic Physics Lecture for the RT: Hybrid Imaging: Past, Present and Future. Chicago, IL, US.
      49. 2015. Nuclear Imaging 1.0. Conference. Nuclear Imaging 1.0. Chicago, IL, US.
      50. 2015. PET Performance Measurements. Conference. PET Performance Measurements. Baltimore, MD, US.
      51. 2015. Uncertainty in PET Image Quantification. Conference. Uncertainty in PET Image Quantification. Baltimore, MD, US.
      52. 2014. Nuclear Imaging 1.0. Conference. Nuclear Imaging 1.0. Chicago, IL, US.
      53. 2014. Web-based Nuclear Medicine Quality Assurance Tool. Conference. Web-based Nuclear Medicine Quality Assurance Tool. Chicago, IL, US.
      54. 2014. Hybrid Imaging in Nuclear Medicine. Conference. Hybrid Imaging in Nuclear Medicine. Chicago, IL, US.
      55. 2014. Thoracic PET-CT: Quantification and interpretation challenges. Conference. Thoracic PET-CT: Quantification and interpretation challenges. San Diego, CA, US.
      56. 2014. Refresher and What's New in PET/Gamma Camera Cardiac Imaging. Conference. Refresher and What's New in PET/Gamma Camera Cardiac Imaging. Denver, CO, US.
      57. 2012. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Conference. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Chicago, IL, US.
      58. 2012. PET/CT QA/QC and Acceptance Testing. Conference. PET/CT QA/QC and Acceptance Testing. Charlotte, NC, US.
      59. 2012. Acceptance testing and QC programs including artifacts and troubleshooting. Conference. Acceptance testing and QC programs including artifacts and troubleshooting. San Diego, CA, US.
      60. 2012. PET/MR: Status update and Opportunities. Conference. PET/MR: Status update and Opportunities. Oklahoma City, OK, US.
      61. 2011. New era of radiotherapy: An update in radiation-induced lung disease. Conference. New era of radiotherapy: An update in radiation-induced lung disease. Chicago, IL, US.
      62. 2011. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Conference. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Chicago, IL, US.
      63. 2011. PET Qualification and artifacts. Conference. PET Qualification and artifacts. Chicago, IL, US.
      64. 2011. Thoracic PET-CT: Quantification and Interpretation Predicaments. Conference. Thoracic PET-CT: Quantification and Interpretation Predicaments. Chicago, IL, US.
      65. 2010. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Conference. PET/CT in the Thorax: Interpretation, pitfalls, and future developments. Chicago, IL, US.
      66. 2010. SPECT/CT and PET/CT installation and testing: Acceptance and QC. Conference. SPECT/CT and PET/CT installation and testing: Acceptance and QC. Chicago, IL, US.
      67. 2010. PET/CT: Technology updates, Quality assurance and Applications. Conference. PET/CT: Technology updates, Quality assurance and Applications. Philadelphia, PA, US.
      68. 2010. The actions we take: The truth about Iodinated Contrast. PET Center of Excellence. Conference. The actions we take: The truth about Iodinated Contrast. PET Center of Excellence. Salt Lake City, UT, US.
      69. 2010. Physics Perspectives on PET Imaging. Conference. Physics Perspectives on PET Imaging. San Antonio, TX, US.
      70. 2010. Thoracic PET-CT: Interpretation predicaments and Future Development. Conference. Thoracic PET-CT: Interpretation predicaments and Future Development. San Diego, CA, US.
      71. 2009. Quantitative Accuracy in PET Imaging. Conference. Quantitative Accuracy in PET Imaging. Chicago, IL, US.
      72. 2009. Educational Exhibit, Physics case of the day. Conference. Educational Exhibit, Physics case of the day. Chicago, IL, US.
      73. 2009. PET/CT Technology Update, Quality Assurance and applications. Conference. American Association of Physics in Medicine. Anaheim, CA, US.
      74. 2009. Quantification in PET/CT Imaging. Conference. Quantification in PET/CT Imaging. Boston, MA, US.
      75. 2009. Positron Emission Mammography. Conference. Positron Emission Mammography. San Antonio, TX, US.
      76. 2008. PET/CT Imaging and Factors Affecting SUV Measurements, The future of Quantitative and functional lung imaging. Conference. PET/CT Imaging and Factors Affecting SUV Measurements, The future of Quantitative and functional lung imaging. Coralville, IA, US.
      77. 2008. PET/CT: Technology Updates, Quality Assurance and Applications. Conference. AAPM Annual Meeting. Houston, TX, US.
      78. 2008. Factors affecting SUV and Quantification. Conference. American Association of Physicists in Medicine Summer School meeting 2008. Houston, TX, US.
      79. 2008. PET ACR Accreditation and Acceptance Testing. Conference. American Association of Physicists in Medicine Summer School meeting 2008. Houston, TX, US.
      80. 2008. Nuclear Medicine Today and Tomorrow: Integrating SPECT/CT for Whole Body Imaging. Conference. Society of Nuclear Medicine Annual Meeting. New Orleans, LA, US.
      81. 2008. Factors Affecting SUV Quantification in PET/CT Imaging. Conference. American Roentgen Ray Society (ARRS) annual meeting. Washington, DC, US.
      82. 2007. Educational Exhibit, Physics case of the day. Conference. Educational Exhibit, Physics case of the day. Chicago, IL, US.
      83. 2007. PET Dosimetry and Factors Affecting Image Quantification. Conference. Annual meeting of the Council on Ionizing Radiation Measurements and Standards. Gaithersbury, MD, US.
      84. 2007. PET CT Workshop: PET/CT Scanner Offering from Different Manufacturers. Conference. PET CT Workshop: PET/CT Scanner Offering from Different Manufacturers. Minneapolis, MN, US.
      85. 2007. PET accreditation and Quality Assurance. Conference. AAPM Annual Meeting. Minneapolis, MN, US.
      86. 2007. QA and QC in quantitative PET/CT imaging. Conference. Society of Nuclear Medicine Annual Meeting. Washington, DC, US.
      87. 2007. PET/CT instrumentation update and review. Conference. Society of Nuclear Medicine Annual Meeting. Washington, DC, US.
      88. 2006. NCI Workshop: Use of PET CT in the Clinic and Clinical Trials: Quantitation for Change Analysis - Quality Assurance for Quantitative PET/CT. Conference. Society of Nuclear Medicine Annual Meeting. Washington, DC, US.
      89. 2006. PET/CT Instrumentation: What's available and how it works - GE PET/CT systems. Conference. Society of Nuclear Medicine Annual Meeting. San Diego, CA, US.
      90. 2006. Quantitative techniques in PET, Academy of Molecular Imaging Annual Meeting. Conference. Quantitative techniques in PET, Academy of Molecular Imaging Annual Meeting. Orlando, FL, US.
      91. 2006. PET and PET/CT instrumentation. Conference. Academy of Molecular Imaging Annual. Orlando, FL, US.
      92. 2005. 4D PET/CT: Instrumentation, image acquisition, and application to radiation therapy planning. Conference. Academy of Molecular Imaging Annual Meeting. Orlando, FL, US.
      93. 2004. From PET to MicroPET Imaging. Conference. 12th Annual Radiation Workshop. Round Top, TX, US.
      94. 2004. Emerging trends in PET/CT imaging. Conference. Academy of Molecular Imaging Annual Meeting. Orlando, FL, US.
      95. 2002. Positron Emission Tomography: Trends and Performance Standards. Conference. South Western Chapter American Association of Physicists in Medicine Annual Meeting. Dallas, TX, US.
      96. 2002. So You're Putting in a PET Scanner. Conference. South Western Chapter Society of Nuclear Medicine 47th Annual Meeting. Galveston, TX, US.
      97. 2001. PET Mini Fellowship 2001. Conference. Columbia University College of Physicians and Surgeons, Department of Radiology. New York, NY, US.
      98. 1997. Multimodality Brain Image Registration using a 3:D Photogrammetrically Derived Surface. Conference. Multimodality Brain Image Registration using a 3:D Photogrammetrically Derived Surface. San Antonio, TX, US.

      International Presentations

      1. 2025. PET II: Quality Assurance, Testing and Quantification. Conference. Advanced Course on Biomedical Imaging, PT.
      2. 2025. Medical Physics Cross Specialization in the Era of Radiotheranostics. Invited. Kuwait City, KW.
      3. 2025. The Role of Novel Radiotracers in Enhancing PET Imaging for Precision Medicine. Invited. Kuwait City, KW.
      4. 2025. TG126 PET/CT acceptance testing and quality assurance. Invited. Kuwait City, KW.
      5. 2023. What is new in Nuclear Medicine from NM physicist perspective. Conference. What is new in Nuclear Medicine from NM physicist perspective, SA.
      6. 2023. Recent advances in PET/CT & SPECT/CT. Conference. Recent advances in PET/CT & SPECT/CT. Skopje, MK.
      7. 2023. PET I: Basics, Advanced Course on Biomedical Imaging. Conference. PET I: Basics, Advanced Course on Biomedical Imaging, PT.
      8. 2023. Medical physics cross specialization in the era of radiotheranostics. Conference. Medical physics cross specialization in the era of radiotheranostics. Muscat, OM.
      9. 2023. PET II: Quality Assurance, Testing and Quantification, Advanced Course on Biomedical Imaging. Conference. PET II: Quality Assurance, Testing and Quantification, Advanced Course on Biomedical Imaging, PT.
      10. 2023. Advances in PET/CT Imaging, Advanced Course on Biomedical Imaging. Conference. Advances in PET/CT Imaging, Advanced Course on Biomedical Imaging, PT.
      11. 2023. PET acceptance testing and quality assurance: AAPM Task Group 126 Report. Conference. PET acceptance testing and quality assurance: AAPM Task Group 126 Report. Muscat, OM.
      12. 2022. QA/QC in PET and SPECT Imaging. Conference. QA/QC in PET and SPECT Imaging, MA.
      13. 2022. Quantification Challenges in PET/CT. Conference. Quantification Challenges in PET/CT, MA.
      14. 2022. Recent Advances in PET/CT Imaging. Conference. Recent Advances in PET/CT Imaging, MA.
      15. 2022. PET II: Quality Assurance, Testing and Quantification. Conference. PET II: Quality Assurance, Testing and Quantification, PT.
      16. 2022. Advances in PET/CT Imaging. Conference. Advances in PET/CT Imaging, PT.
      17. 2022. PET I: Basics. Conference. PET I: Basics, PT.
      18. 2022. PET Parameters Standardization; SUV, MTV and TLG. Conference. PET Parameters Standardization; SUV, MTV and TLG, SA.
      19. 2022. Recent Advances in PET/CT. Conference. Recent Advances in PET/CT, SA.
      20. 2022. Acceptance Testing of PET Using AAPM TG-126. Conference. Acceptance Testing of PET Using AAPM TG-126, SA.
      21. 2022. Image Reconstruction Algorithms and Image Optimizing in PET/CT. Conference. Image Reconstruction Algorithms and Image Optimizing in PET/CT, SA.
      22. 2021. Recent Advances in PET/CT and PET/MR Designs. Conference. Recent Advances in PET/CT and PET/MR Designs, KW.
      23. 2021. Advances in PET Imaging. Conference. Advances in PET Imaging, IN.
      24. 2020. Digital PET Scanner. Conference. Digital PET Scanner, SA.
      25. 2020. Quantification in PET-CT Imaging. Conference. Quantification in PET-CT Imaging, SA.
      26. 2020. Image Reconstruction Algorithms and Image Optimizing in PET/CT. Conference. Image Reconstruction Algorithms and Image Optimizing in PET/CT, SA.
      27. 2020. State of the Art and Future Perspectives in PET Imaging. Conference. State of the Art and Future Perspectives in PET Imaging, SA.
      28. 2019. Fundamentals of SPECT & SPECT-CT. Conference. International Symposium on Medical Imaging Physics & Image Guidance in Radiotherapy, IN.
      29. 2019. Fundamentals of PET & PET-CT. Conference. International Symposium on Medical Imaging Physics & Image Guidance in Radiotherapy, IN.
      30. 2019. Advances in PET, SPECT and QA/QC in PET and SPECT. Conference. International Symposium on Medical Imaging Physics & Image Guidance in Radiotherapy, IN.
      31. 2019. PET/CT QC. Conference. PET/CT QC, SA.
      32. 2019. PET SUV and the Future of Digital PET. Conference. PET SUV and the Future of Digital PET. Ottawa, CA.
      33. 2017. Basic Gamma Camera/SPECT and QC Physics. Conference. Basic Gamma Camera/SPECT and QC Physics, PE.
      34. 2017. Advances in PET and SPECT (Including PET/MR). Conference. Advances in PET and SPECT (Including PET/MR), PE.
      35. 2017. Testing/Commissioning of PET and Gamma Camera. Conference. Testing/Commissioning of PET and Gamma Camera, PE.
      36. 2017. Basic PET/CT Camera and QC Physics. Conference. Basic PET/CT Camera and QC Physics, PE.
      37. 2013. Quantification in Hybrid Modalities. Conference. Quantification in Hybrid Modalities. Bangkok, TH.
      38. 2013. PET/CT Testing/QA and Dose Reduction Techniques. Conference. PET/CT Testing/QA and Dose Reduction Techniques. Bangkok, TH.
      39. 2013. Advantages and Advances in Nuclear hybrid Imaging systems. Conference. Advantages and Advances in Nuclear hybrid Imaging systems. Bangkok, TH.
      40. 2013. Overview of PET Quantification for Radiopharmaceutical Dosimetry. Conference. Overview of PET Quantification for Radiopharmaceutical Dosimetry. Vancouver, CA.
      41. 2013. Thoracic PET-CT: Quantification and Interpretation Predicaments. Conference. Thoracic PET-CT: Quantification and Interpretation Predicaments. Vancouver, CA.
      42. 2012. PET/CT, SPECT/CT and gamma camera: Acceptance and annual testing: Diagnostic Imaging Workshop. Conference. PET/CT, SPECT/CT and gamma camera: Acceptance and annual testing: Diagnostic Imaging Workshop. Buenos Aires, AR.
      43. 2012. PET/CT, SPECT/CT and gamma camera: Dosimetry. Diagnostic Imaging workshop. Conference. PET/CT, SPECT/CT and gamma camera: Dosimetry. Diagnostic Imaging workshop. Buenos Aires, AR.
      44. 2012. PET/CT, SPECT/CT and gamma camera: Emerging technologies in Nuclear Medicine Diagnostic Imaging workshop. Conference. PET/CT, SPECT/CT and gamma camera: Emerging technologies in Nuclear Medicine Diagnostic Imaging workshop. Buenos Aires, AR.
      45. 2012. PET/CT, SPECT/CT and gamma camera: Basic Physics and Quality Assurance: Diagnostic Imaging Workshop. Conference. PET/CT, SPECT/CT and gamma camera: Basic Physics and Quality Assurance: Diagnostic Imaging Workshop. Buenos Aires, AR.
      46. 2012. Thoracic PET-CT: Quantification and Interpretation Predicaments. Conference. Thoracic PET-CT: Quantification and Interpretation Predicaments. Vancouver, CA.
      47. 2012. PET/CT QA/QC and Acceptance Testing. Conference. PET/CT QA/QC and Acceptance Testing. Riyadh, SA.
      48. 2012. 4D PET/CT imaging and its applications in oncology. Conference. 4D PET/CT imaging and its applications in oncology. Riyadh, SA.
      49. 2012. Advances in PET imaging. Conference. Advances in PET imaging. Riyadh, SA.
      50. 2012. Quantification in PET/CT imaging: Barriers and solutions. Conference. Quantification in PET/CT imaging: Barriers and solutions. Riyadh, SA.
      51. 2011. CT scanner settings and image quality. Conference. CT scanner settings and image quality. Muscat, OM.
      52. 2011. Patient dose in CT imaging. Conference. Patient dose in CT imaging. Muscat, OM.
      53. 2011. PET acceptance testing. Conference. PET acceptance testing. Porto Alegre, BR.
      54. 2011. PET QA/QC and TG updates. Conference. PET QA/QC and TG updates. Porto Alegre, BR.
      55. 2011. Advances in Quantitative PET/CT. Conference. Advances in Quantitative PET/CT. Porto Alegre, BR.
      56. 2011. PET recent technology updates. Conference. PET recent technology updates. Porto Alegre, BR.
      57. 2011. PET Accreditation. Conference. PET Accreditation. Porto Alegre, BR.
      58. 2010. Quantification accuracy in Brain PET imaging. Conference. Quantification accuracy in Brain PET imaging, TW.
      59. 2010. Quantification accuracy in Brain PET imaging. Conference. Quantification accuracy in Brain PET imaging, TW.
      60. 2009. Techniques for Reducing Motion Artifacts in PET/CT Imaging. Conference. Techniques for Reducing Motion Artifacts in PET/CT Imaging. Hangzhou, CN.
      61. 2009. Multimodality Equipment Quality Control Issues. Conference. Multimodality Equipment Quality Control Issues. Toronto, CA.
      62. 2009. PET/CT Instrumentation, A Technology Update. Conference. PET/CT Instrumentation, A Technology Update. Toronto, CA.
      63. 2009. Implementation and Optimization of a New Super Resolution Technique in PET Imaging. Conference. Implementation and Optimization of a New Super Resolution Technique in PET Imaging. Boston, US.
      64. 2007. Artifacts and Quantification in PET/CT Imaging. Conference. International symposium on Imaging Science and technology in Drug discovery and development. Sendai, JP.
      65. 2005. PET/CT Instrumentation: What's available and how it works - GE PET/CT systems. Conference. Society of Nuclear Medicine Annual Meeting. Toronto, CA.
      66. 2005. PET/CT: The tried and true and a look at what's new: PET/CT instrumentation. Conference. Society of Nuclear Medicine Annual Meeting. Toronto, CA.

      Formal Peers

      1. 2024. PET II: Quality Assurance. Portugal (Virtual), PT.
      2. 2024. PET I: Basics. Portugal (Virtual), PT.
      3. 2024. Advances in PET/CT Imaging. Portugal (Virtual), PT.
      4. 2024. Quadra PET/CT. Houston, Texas, US.
      5. 2022. Advances in PET Imaging. Invited, GR.
      6. 2022. Nuclear Medicine Medical Physics Pathway in the USA. Invited, GR.
      7. 2022. Opportunities in Clinical Support for NM physicists. Invited. Baltimore, MD, US.
      8. 2018. Advances in PET Imaging. Invited. Winston-Salem, NC, US.
      9. 2018. Quantification Challenges in PET/CT Imaging. Invited. Winston-Salem, NC, US.
      10. 2017. Advances in PET imaging: motion correction, proton therapy verification and PET/MR. Invited. New Haven, CT, US.
      11. 2012. Dose issues in PET and CT imaging of small animals. Invited. Houston, TX, US.
      12. 2009. Factors affecting PET/CT quantification. Invited. Houston, TX, US.
      13. 2009. The physics of PET/CT. Invited. Houston, TX, US.
      14. 2008. Image processing and Visualization techniques applied to cancer imaging: Image Quantification. Invited. Sao Paulo, BR.
      15. 2007. Clinical Impact of 4D CT and 4D PET/CT in Cancer Diagnosis and Therapy. Invited. Las Vegas, NV, US.
      16. 2004. 4D PET using LIST mode data acquisition. Invited. Las Vegas, NV, US.
      17. 2003. The role of PET/CT in radiation oncology. Invited. Houston, TX, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2027 - 2031
      Title:PP2A Targeting to Overcome CRIP1-Mediated Radiation Resistance During Re-Irradiation
      Funding Source:NIH
      Role:Co-PI
      ID:1R01CA322883-01
      Date: 2025 - 2027
      Title:Evaluation of Targeted Radionuclide Therapy of LU-177 PAMA in patients with compromised renal and/or bone marrow function
      Funding Source:GE Healthcare
      Role:Co-PI
      Date: 2023 - 2025
      Title:Comprehensive Assessment of Cancer Theranostics Response
      Funding Source:NIH/NCI
      Role:Co-I
      ID:5R44CA2850006-02
      Date: 2022 - 2027
      Title:Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology
      Funding Source:NIH/NCI
      Role:Co-Mentor
      ID:5T32CA196561-08
      Date: 2021 - 2024
      Title:A novel PARP inhibitor PET tracer for breast cancer
      Funding Source:NIH/NCI
      Role:Co-I
      ID:5R01CA249329-02
      Date: 2020 - 2021
      Title:WS#29 Establish the minimum detectable PET activity concentrations when imaging F-18 and Ga-68 labeled prostate cancer radiotracers with the Sigma PET/MR
      Funding Source:GE Healthcare
      Role:Collaborator
      ID:00058508
      Date: 2020 - 2022
      Title:A Multicenter, Randomized, Controlled Phase 2 Study: Efficacy and Safety of I-131-1095 Radiotherapy in Combination with Enzalutamide in Metastatic Castration- Resistant Prostate Cancer (mCRPC) patients who are 18F-DCFPyL prostate-specific membrane antigen (PSMA)-avid, chemotherapy naive, and progressed on Abiraterone (ARROW)
      Funding Source:Progenics
      Role:Collaborator
      ID:2019-0364
      Date: 2020 - 2023
      Title:A novel PARP inhibitor PET tracer for breast cancer
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2019 - 2027
      Title:A Multicenter, Randomized, Controlled Phase 2 Study: Efficacy and Safety of I-131-1095 Radiotherapy in Combination with Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients Who Are 18F-Dcfpyl Prostate-Specific Membrane Antigen (ARROW)
      Funding Source:Progenics
      Role:Collaborator
      ID:2019-0364
      Date: 2019 - 2020
      Title:Data Driven gating (DDG) for PET Imaging
      Funding Source:Siemens
      Role:PI
      ID:PA18-0247
      Date: 2019 - 2022
      Title:[18F]FAZA PET/CT for Monitoring Target Engagement of a Novel Complex I Inhibitor
      Funding Source:NIH/NCI
      Role:Co-I
      ID:5R01CA231506-02
      Date: 2019 - 2022
      Title:Study to Establish the Diagnostic Performance of 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases after Radiation Therapy Metastases After Radiation Therapy
      Funding Source:Blue Earth Diagnostics, Ltd
      Role:Co-I
      ID:58728
      Date: 2019 - 2020
      Title:An international multi-center, open-label study to evaluate safety, tolerability, biodistribution, dosimetry and preliminary efficacy of 177Lu-OPS201 for the therapy of somatostatin receptorpositive neuroendocrine tumors (NETs)
      Funding Source:IPSEN PHARMA SAS
      Role:Co-I
      ID:2018-0818
      Date: 2019 - 2020
      Title:An International Multi-Centre, Open-Label Radioactivity Escalation Phase I/IIa Study to Evaluate the Safety, Tolerability, Biodistribution and Preliminary Anti-Tumour Activity of 177Lu-OPS201 for Therapy in Previously Treated Patients
      Funding Source:IPSEN PHARMA SAS
      Role:Co-I
      ID:2018-0586
      Date: 2016 - 2018
      Title:Selective Photothermal Ablation of HCC with Renal Clearable [64Cu]CuS Nanodots
      Funding Source:GE-Cabi, General Electric
      Role:Collaborator
      Date: 2016 - 2019
      Title:Pre-Clinical Development of SUPR Peptides as PET Imaging Agents for Her2-positive Breast Cancer
      Funding Source:EvoRx Technologies, Inc
      Role:Co-I
      Date: 2015 - 2018
      Title:Characterization of Flow Motion Effects on Image Quality and Patient Experience
      Funding Source:Siemens
      Role:PI
      ID:2015-MI-02-01-Mawlawi-C00219932
      Date: 2015 - 2017
      Title:4D PET/CT Using HD Chest on Siemens mCT Scanner
      Funding Source:Siemens
      Role:PI
      Date: 2015 - 2018
      Title:Phase 1 Dose-escalation study of Radio-labeled Immunotherapeutic, FF-21101(90Y) for the Treatment of Advanced Cancer
      Funding Source:Strategia Therapeutics, Inc
      Role:Co-I
      ID:2015-0220-V101
      Date: 2015 - 2016
      Title:SUPR Peptides for Targeted Radionuclide Delivery
      Funding Source:NIH/SBIR with EvoRX
      Role:Co-I
      Date: 2015 - 2018
      Title:An Open-Label Multicenter Phase 1 Study of E7046
      Funding Source:Eisai Inc
      Role:Co-I
      ID:2015-0384/ G000 101
      Date: 2015 - 2017
      Title:Dosimetry for Lu-177 DOTATE for Peptide Receptor Radionuclide Therapy (PRRT) for progressive metastatic Neuroendocrine Cancer
      Funding Source:RITA Foundation
      Role:Principal Investigator-MDACC
      ID:15060849
      Date: 2014 - 2018
      Title:Dosimetry for AminoMedix for Radiation Kidney protection during Peptide-Receptor Radionuclide Therapy (PRRT): Phase I, II Clinical Trial
      Funding Source:RadioMedix
      Role:PI
      Date: 2014 - 2017
      Title:Quantitative 90Y PET/CT: Quest Site Assessment Study
      Funding Source:SIRTEX Medical Limited
      Role:Co-I
      Date: 2014 - 2016
      Title:Evaluation of regularized image reconstruction in whole body PET/CT Imaging
      Funding Source:MDACC/GE-CABI
      Role:Principal Investigator-MDACC
      ID:N/A
      Date: 2014 - 2014
      Title:Dosimetry of the novel radiotracer 111ln-FF21101 in non-human primates
      Funding Source:Boston Strategies
      Role:Co-I
      Date: 2013 - 2016
      Title:4D PET/CT imaging in lung and colorectal cancer with liver metastasis
      Funding Source:MDACC/GE-CABIR
      Role:Principal Investigator-MDACC
      ID:SR2008-00023834EB
      Date: 2012 - 2014
      Title:Evaluate the potential and limits of reducing scan time and/or injected activity in multi-gated blood pool (MUGA) imaging using IQ SPECT
      Funding Source:SIEMENS Medical Solutions
      Role:PI
      Date: 2011 - 2015
      Title:Improving Cord Blood Transplant
      Funding Source:NIH/NCI
      Role:Co-I
      ID:5 P01 CA148600-03
      Date: 2010 - 2012
      Title:Standardization of PET Quantification Across Different Image Acquisition, Processing Parameters and Scanner Platforms
      Funding Source:Institutional Research Grant
      Role:PI
      ID:UTMDACC
      Date: 2008 - 2008
      Title:Motion Correction of PET DATA Using Amplitude Gating
      Funding Source:GE Medical Solutions
      Role:PI
      ID:SR2008-00023792EB
      Date: 2007 - 2007
      Title:Comparison of image quality between D-ST and D-RX using standard versus Vue Point reconstruction in 2D and 3D modes
      Funding Source:GE Healthcare
      Role:PI
      ID:CS2006-00017040SS
      Date: 2006 - 2009
      Title:Whole Body Bone Scanning with SPECT/CT
      Funding Source:SIEMENS Medical
      Role:PI
      ID:SR2007-00018831JW
      Date: 2006 - 2007
      Title:PET Image Reconstruction with Motion Compensation
      Funding Source:GE Healthcare
      Role:PI
      ID:CS2006-00017039SS
      Date: 2003 - 2005
      Title:Accurate quantification of lung cancer lesion based on PET/CT imaging
      Funding Source:Society of Thoracic Radiology
      Role:PI
      Date: 2003 - 2005
      Title:Radiation Dosimetry of Intra-tumoral Injection of Radionuclides in Human Breast Cancer
      Funding Source:N/A
      Role:Collaborator
      ID:DAMD 17-03-1-0455
      Date: 2003 - 2005
      Title:PET/CT Imaging in the Presence of X-Ray Contrast Enhancing Agents
      Funding Source:GE Medical Solutions
      Role:PI
      ID:LS2003-00009876HM
      Date: 2003 - 2005
      Title:Accurate quantification of small lung nodules based on PET/CT images
      Funding Source:GE Medical Solutions
      Role:PI
      ID:CS2003-00009880HM
      Date: 2001 - 2006
      Title:NO TITLE PROVIDED
      Funding Source:NIH/NCI
      Role:Collaborator
      ID:R01 CA089198

      Selected Publications

      Peer-Reviewed Articles

      1. Dagher SA, Johnson JM, Mohamed RMM, Ansari S, Mawlawi O, Liu HL, Wintermark M, Schellingerhout D, Flynt L, Yeboa DN, Weinberg JS, Ferguson SD, Gule-Monroe MK. Study of 18 F-fluciclovine PET for serial assessment of glioblastoma tumor volumes during surgery and radiotherapy. J Neurooncol 175(2):549-560, 2025. e-Pub 2025. PMID: 40591209.
      2. Msherghi A, Salim HA, Alizada S, Wong F, Xu G, Mawlawi O, Elhadi M, Alsharedi M, Ray WJ, Puduvalli VK, Wintermark M. 18F-FDG PET Reveals Voxel-Based Decreases in Brain Glucose Uptake After Chemotherapy in Leukemia Patients: A Retrospective Matched-Control Study. J Nucl Med 66(12):1883-1890, 2025. e-Pub 2025. PMID: 41101978.
      3. Ding S, Barbee RM, Mawlawi OR, Pan T. Automatic trending and analysis of SPECT quality assurance with artificial intelligence optical character recognition. Med Phys 52((8):e):18083, 2025. e-Pub 2025. PMID: 40903927.
      4. Parker SA, Weygand J, Bernat BG, Jackson AM, Mawlawi O, Barreto I, Hao Y, Khan R, Yorke AA, Swanson W, Huq MS, Lief E, Biancia CD, Njeh CF, Al-Basheer A, Chau OW, Avery S, Ngwa W, Sandwall PA. Assessing Radiology and Radiation Therapy Needs for Cancer Care in Low-and-Middle-Income Countries: Insight From a Global Survey of Departmental and Institutional Leaders. Adv Radiat Oncol 9(11):101615, 2024. e-Pub 2024. PMID: 39410956.
      5. Fraum TJ, Sari H, Dias AH, Munk OL, Pyka T, Smith AM, Mawlawi OR, Laforest R, Wang G. Whole-Body Multiparametric PET in Clinical Oncology: Current Status, Challenges, and Opportunities. AJR Am J Roentgenol 223(5), 2024. e-Pub 2024. PMID: 39230403.
      6. AlMazrou RY, Alanazi SF, Alzaid MH, Al-Fakhranee RS, Ding S, Mawlawi OR. Performance characteristics of the 5-ring GE Discovery MI PET/CT scanner using AAPM TG-126 report. J Appl Clin Med Phys 25(4):e14315, 2024. e-Pub 2024. PMID: 38415897.
      7. Cesar, J, Abouzahr, F, Crespo, P, Gajda, M, Kuo, AS, Mawlawi, O, Morozov, A, Ojha, A, Poenisch, F, Proga, M, Sahoo, N, Seco, J, Takaoka, T, Tavienier, S, Titt, U, Wang, X, Zhu, X, Lang, K. First PET Studies of a FLASH Proton Beam. Bio-Algorithms and Med-Systems 20:49-54, 2024. e-Pub 2024.
      8. Abouzahr F, Cesar JP, Crespo P, Gajda M, Hu Z, Klein K, Kuo AS, Majewski S, Mawlawi, O, Morozov A, Ojha A, Poenisch F, Proga M, Sahoo N, Seco J, Takaoka T, Tavernier S, Titt U, Wang X, Zhu XR, Lang K. The first probe of a FLASH proton beam by PET. Phys Med Biol 68(23), 2023. e-Pub 2023. PMID: 37918021.
      9. Ravizzini G, Erwin W, De Palatis L, Martiniova L, Subbiah V, Paolillo V, Mitchell J, McCoy AP, Gonzalez J, Mawlawi, O. Dosimetry of a Novel 111Indium-Labeled Anti-P-Cadherin Monoclonal Antibody (FF-21101) in Non-Human Primates. Cancers (Basel) 15(18), 2023. e-Pub 2023. PMID: 37760501.
      10. Abouzahr F, Cesar JP, Crespo P, Gajda MJ, Hu Z, Kaye W, Klein K, Kuo A, Majewski S, Mawlawi, O, Morozov A, Ojha A, Poenisch F, Polf JC, Proga M, Sahoo N, Seco J, Takaoka T, Tavernier S, Titt U, Wang X, Zhu XR, Lang K. The first PET glimpse of a proton FLASH beam. Phys Med Biol. e-Pub 2023. PMID: 37141903.
      11. Nguyen TDT, Wang Y, Bui TN, Lazcano R, Ingram DR, Yi M, Vakulabharanam V, Luo L, Pina MA, Karakas C, Li M, Kettner NM, Somaiah N, Hougton PJ, Mawlawi, O, Lazar AJ, Hunt KK, Keyomarsi K. Sequential targeting of retinoblastoma and DNA synthesis pathways is a therapeutic strategy for sarcomas that can be monitored in real-time. Cancer Res 83(6):939-955, 2023. e-Pub 2023. PMID: 36603130.
      12. Meier JG, Diab RH, Connor TM, Mawlawi, O. Impact of low injected activity on data driven respiratory gating for PET/CT imaging with continuous bed motion. J Appl Clin Med Phys 23(5):e13619, 2022. e-Pub 2022. PMID: 35481961.
      13. Catana C, Laforest R, An H, Boada F, Cao T, Faul D, Jakoby B, Jansen FP, Kemp BJ, Kinahan PE, Larson P, Levine MA, Maniawski P, Mawlawi, O, McConathy JE, McMillan AB, Price JC, Rajagopal A, Sunderland J, Veit-Haibach P, Wangerin KA, Ying C, Hope TA. A Path to Qualification of PET/MR Scanners for Multicenter Brain Imaging Studies: Evaluation of MR-based Attenuation Correction Methods Using a Patient Phantom. J Nucl Med 63(4):615-621, 2022. e-Pub 2022. PMID: 34301784.
      14. Thomas MA, Meier JG, Mawlawi, O, Sun P, Pan T. Impact of acquisition time and misregistration with CT on data-driven gated PET. Phys Med Biol 67(8):10, 2022. e-Pub 2022. PMID: 35313286.
      15. Seyedin SN, Bassalow R, Mawlawi, O, Turner LM, Patel RR, Mazin SR, Oderinde OM, Voronenko Y, Wages CA, Olcott PD, Chang JY, Balter PA, Welsh JW. The potential of biology-guided radiation therapy in thoracic cancer: A preliminary treatment planning study. Front Oncol 12:921473, 2022. e-Pub 2022. PMID: 36313653.
      16. Wallis JW, Klein R, Bradshaw TJ, Catana C, Hatt M, Laforest R, Liu C, Mawlawi, O, McCall KC, Osborne DR, Tang J, Wells RG, Ghesani M. Guidelines on Setting Up Stations for Remote Viewing of Nuclear Medicine and Molecular Imaging Studies During COVID-19.. J Nucl Med Technol 49(1):2-6, 2021. e-Pub 2021. PMID: 33380520.
      17. Lopez BP, Jordan DW, Kemp BJ, Kinahan PE, Schmidtlein CR, Mawlawi OR. PET/CT acceptance testing and quality assurance: Executive summary of AAPM Task Group 126 Report. Med Phys 48(2):e31-e35, 2021. e-Pub 2021. PMID: 33320364.

      Other Articles

      1. Sun Y, Mawlawi OR Legopet: Hierarchical feature guided conditional diffusion for pet image reconstruction. 2025 IEEE 22nd International Symposium on Biomedical Imaging (ISBI):1-5, 2025.
      2. Sun Y, Baroudi H, Netherton T, Court L, Mawlawi OR, Veeraraghavan A, Balakrishnan G Difr3ct: Latent diffusion for probabilistic 3d ct reconstruction from few planar x-rays. ArXiv, 2024.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 29, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top